Full text
PDFPage 745
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fullerton P. M., O'Sullivan D. J. Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study. J Neurol Neurosurg Psychiatry. 1968 Dec;31(6):543–551. doi: 10.1136/jnnp.31.6.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsden P. D., Knight R. Halogenated oxyquinoline derivatives. Lancet. 1971 Apr 24;1(7704):854–854. doi: 10.1016/s0140-6736(71)91514-5. [DOI] [PubMed] [Google Scholar]
- Richards D. A. A controlled trial in travellers' diarrhoea. Practitioner. 1970 Jun;204(224):822–824. [PubMed] [Google Scholar]
- Richards D. A. Prophylactic value of clioquinol against travellers' diarrhoea. Lancet. 1971 Jan 2;1(7688):44–45. doi: 10.1016/s0140-6736(71)80056-9. [DOI] [PubMed] [Google Scholar]
- Sobue I., Ando K., Iida M., Takayanagi T., Yamamura Y., Matsuoka Y. Myeloneuropathy with abdominal disorders in Japan. A clinical study of 752 cases. Neurology. 1971 Feb;21(2):168–173. doi: 10.1212/wnl.21.2.168. [DOI] [PubMed] [Google Scholar]
- Tsubaki T., Honma Y., Hoshi M. Neurological syndrome associated with clioquinol. Lancet. 1971 Apr 3;1(7701):696–697. doi: 10.1016/s0140-6736(71)92699-7. [DOI] [PubMed] [Google Scholar]